The angiotensin-converting enzyme (ACE) gene has been found to be associated with pathogenesis and progression of diabetic retinopathy (DR). A recent meta-analysis comprising 2,224 Chinese patients showed moderate evidence of a relationship between the ACE insertion/deletion (I/D) polymorphism and proliferative diabetic retinopathy (PDR) 1 ; however, the role of other renin-angiotensin system (RAS) polymorphisms and their possible interactions with ACE I/D genotypes are less Multivariate logistic regression was used to compute the odds ratio for developing diabetic retinopathy by adjusting for potential confounders, which include age, sex, glycated hemoglobin, duration of diabetes, smoking, systolic blood pressure and triglyceride levels, angiotensin converting enzyme inhibitor/angiotensin II type 1 receptor blocker, serum creatinine and estimated glomerular filtration rate. Genomic DNA was isolated from peripheral blood using the proteinase K chloroform-phenol method. Genotyping was carried out using allele-specific oligonucleotide polymerase chain reaction and polymerase chain reaction restriction fragment length polymorphism assays. The study was approved by the Postgraduate Institute of Medical Education and Research, Chandigarh ethics committee and written consent was obtained from participating subjects. Cohort 1 and 2 were two independently ascertained cohorts of North Indian origin, which cannot be merged. ACE, angiotensin-converting enzyme; AGT, angiotensinogen; AGTR1, angiotensin II receptor type 1; DM, diabetes mellitus; NPDR, non-proliferative diabetic retinopathy; OR, odds ratio; PDR, proliferative diabetic retinopathy.